Walther P J
Department of Surgery, Duke University School of Medicine, Durham, North Carolina, USA.
Surg Oncol Clin N Am. 1995 Apr;4(2):315-34.
The development of new technologies has stimulated a crusade of screening for earlier detection of prostate cancer. This effort has resulted in controversy regarding its clinical use in this format. Until randomized clinical screening trials define the value of prostate cancer screening, clinicians who use screening approaches must gain a strong understanding of the natural history of the disease, the strengths and weaknesses of available screening methodologies, and epidemiologic considerations of prostate cancer risk.
新技术的发展引发了一场前列腺癌早期检测筛查运动。这一举措在其临床应用方面引发了争议。在随机临床筛查试验确定前列腺癌筛查的价值之前，采用筛查方法的临床医生必须深入了解该疾病的自然史、现有筛查方法的优缺点以及前列腺癌风险的流行病学因素。
